Diseases, Conditions, Syndromes

Antibody treatment tested as new tool against malaria

Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.

Diseases, Conditions, Syndromes

UK-wide study reveals harm done by people not getting COVID jabs

More than 7,000 people were hospitalized or died from COVID-19 in the UK during the summer of 2022 because they had not received the recommended number of vaccine doses, according to a study released Tuesday that was the ...

Diseases, Conditions, Syndromes

New SARS-CoV-2 variant Eris on the rise, study shows

As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells. In response, the virus develops ...

Diseases, Conditions, Syndromes

COVID long-haulers face stigma: Study

High levels of stigma experienced by some COVID long-haulers are associated with more intense symptoms, reduced physical function and loss of employment due to disability, according to newly published research in eClinicalMedicine.

page 5 from 40